News and Events
More News
-
Behind the scenes of WA’s medical innovation: OMRI tours BioCina’s manufacturing facilities 18 December 2025 Western Australia is accelerating from research to advanced manufacturing—showcasing what’s already happening here and inviting more innovators to fill the gaps they see. This month, the Office of Medical Research and Innovation (OMRI) team visited BioCina’s facility at Technology Park – an operation with a unique combination of capabilities in WA, highlighting the state’s growing strength in medical manufacturing. BioCina’s work demonstrates what is possible when science, technology, and industry converge to meet global needs. Their advanced capabilities in medical manufacturing at their 34,000 sqm state-of-the-art facility include the development of aseptic and terminally sterilised injectables, Blow-Fill-Seal technology and products and the safe handling and filling of cytotoxic products. They are now also offering process and analytical development... -
.png)
Stakeholder Update: QEII Health and Biomedical Precinct governance and next steps 17 December 2025 As the year draws to a close, we are pleased to provide stakeholders with an update on the development of the QEII Health and Biomedical Precinct. Your ongoing interest and feedback have been invaluable in shaping the direction of this important initiative. Independent Chair appointed The Minister for Medical Research recently announced the appointment of Ms Paula Rogers as the inaugural Independent Chair of the Precinct Leadership Group (PLG). Paula brings extensive experience in strategic leadership and stakeholder engagement and will commence her role in the new year following her tenure as CEO of the Committee for Perth. Precinct Leadership Group (PLG) The PLG will serve as the primary advisory body during the 18-month establishment phase of the Precinct, which is being led by the Department of Health. The group’s membership includes: Independent Chair: Ms Pau... -
Independent Chair appointed to lead QEII Health and Biomedical Precinct 12 December 2025 Western Australia’s Health and Biomedical Precinct at Queen Elizabeth II Medical Centre (QEII) today reached a significant milestone with the appointment of Ms Paula Rogers as the inaugural Independent Chair of the Precinct Leadership Group (PLG). Supported by a $1.9 million investment from the WA Government, the PLG is tasked with guiding the development of the Precinct’s long-term vision and governance structure. The aim is for the Precinct to become an independently governed, self-sustaining entity by 2027, enhancing collaboration between universities, health service providers, and industry. The QEII Precinct is set to become one of the largest health and biomedical hubs in the southern hemisphere, driving improvements in research translation and innovation across WA. Ms Rogers brings extensive experience in stakeholder engagement and strategic leadership, having previousl... -
Spotlight on RHD 2025 Information Session: Recording and slides now available 10 December 2025 The Office of Medical Research and Innovation (OMRI) recently hosted a virtual information session for the inaugural Future Health Research and Innovation (FHRI) Fund Spotlight Program, focusing on Rheumatic Heart Disease (RHD). The session, led by Stacey Waters, provided an overview of the Spotlight Program’s objectives, application process, and the unique opportunity it presents for Western Australia’s health and medical research sector. Attendees learned about the two-stage funding model—offering up to $25 million over five years—and the program’s emphasis on sector-wide collaboration, community engagement, and translational impact. Key highlights included: The Spotlight Program is the flagship initiative of the FHRI Fund Strategy 2025–30, designed to address a major WA health challenge each year. The 2025–26 theme is RHD, a preventa... -
WA’s innovation start-ups take off with WAVCI support 10 December 2025 Western Australia’s innovation ecosystem is gaining strength through the Western Australian Venture Capital Initiative (WAVCI), which has delivered strong results in its first year. The initiative is designed to expand the pool of venture capital available in WA and accelerate the growth of high-potential businesses across the State’s priority sectors. This funding will help founders access critical early-stage capital, enabling growth, commercialisation, and job creation. Seven venture capital funds have been appointed under the program: Artesian, Brandon Capital Partners and Health Translation Group will focus on health and medical opportunities, while Melt Ventures, Skalata Ventures, Purpose Ventures and FundWA will focus on other priority sectors for WA. All participating funds are establishing or expanding a WA presence, bringing new expertise, networks, and investment o...
Last Updated:
22/05/2025